Concepedia

Peter Connick

PC

27

Publications

1.9K

Citations

20

H-Index

2009

Active since

Affiliations

University of Edinburgh(Current)

University College London

MRC Centre for Regenerative Medicine

National Hospital for Neurology and Neurosurgery

University of Cambridge

Peter Connick is an author at University of Edinburgh specializing in medicine, multiple sclerosis, and neurology.

ORCID

Top concepts

Publications per year

2009–2023

27

Publications

27

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

Peter Connick, Madhan Kolappan, Charles Crawley et al. · The Lancet Neurology · 2012 · 602 citations · Full text

Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course

Xiaoyuan Zhou, Ryan Baumann, Xiaohui Gao et al. · Cell · 2022 · 278 citations · Full text

, , +12

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Jeremy Chataway, Floriana De Angelis, Peter Connick et al. · The Lancet Neurology · 2020 · 124 citations · Full text

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

Peter Connick, Madhan Kolappan, Rickie Patani et al. · Trials · 2011 · 118 citations · Full text

Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study

J William L Brown, Nick Cunniffe, Ferrán Prados et al. · The Lancet Neurology · 2021 · 89 citations · Full text

, , +7

Rows per page

1–5 of 27